Susquehanna International Group, LLP Arcturus Therapeutics Holdings Inc. Transaction History
Susquehanna International Group, LLP
- $641 Billion
- Q4 2024
A detailed history of Susquehanna International Group, LLP transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 54,417 shares of ARCT stock, worth $747,145. This represents 0.0% of its overall portfolio holdings.
Number of Shares
54,417
Previous 38,768
40.37%
Holding current value
$747,145
Previous $899,000
2.67%
% of portfolio
0.0%
Previous 0.0%
Shares
23 transactions
Others Institutions Holding ARCT
# of Institutions
168Shares Held
26MCall Options Held
163KPut Options Held
173K-
Federated Hermes, Inc. Pittsburgh, PA4.69MShares$64.4 Million0.19% of portfolio
-
Black Rock Inc. New York, NY2.65MShares$36.4 Million0.0% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.2.07MShares$28.4 Million0.02% of portfolio
-
Nikko Asset Management Americas, Inc.2.07MShares$28.4 Million0.39% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl1.93MShares$26.6 Million0.29% of portfolio
About Arcturus Therapeutics Holdings Inc.
- Ticker ARCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,576,400
- Market Cap $365M
- Description
- Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...